Conolidine’s analgesic outcomes stem from its conversation with non-opioid pain pathways. As opposed to opioids, which bind to µ-opioid receptors from the central anxious technique, conolidine modulates alternate molecular targets. A Science Innovations study identified that conolidine interacts with the atypical chemokine receptor ACKR3/CXCR7, … Read More

A pivotal study released in “Character” discovered that conolidine offers considerable analgesic consequences in rodent versions, suggesting a promising alternate for suffering management. This analyze emphasizes conolidine’s probable to engage suffering pathways differently than regular suffering relievers, which might be transformative for … Read More